Skip to main content
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: Proceedings (IEEE Int Conf Bioinformatics Biomed). 2020 Feb 6;2019:1703–1707. doi: 10.1109/bibm47256.2019.8982933

TABLE I.

Clinical Characteristics and Outcomes by Hyperchloremia Status over Days 1–7

All Patients
(n = 48074)
Non-Hyperchloremic
(n = 29893)
Hyperchloremic
(n = 18181)
p-value
Demographics
 Age, median (IQR) 65.7 (52.9–77.8) 65.0 (52.4–77.4) 66.9 (53.8–78.5) < 0.001
 Female, n (%) 21008 (43.7) 12684 (42.4) 8324 (45.8) < 0.001
Race, n (%)
 White 34407 (71.6) 21477 (71.8) 12930 (71.1) < 0.001
 Black 4620 (9.6) 3006 (10.1) 1614 (8.9)
 Hispanic 1651 (3.4) 1053 (3.5) 598 (3.3)
 Asian 1121 (2.3) 603 (2.0) 518 (2.8)
 Other (Unreported) 6275 (13.1) 3754 (12.6) 2521 (13.9)
Comorbid Conditions, n (%)
 Cancer 4576 (9.5) 3088 (10.3) 1488 (8.2) < 0.001
 Cardiovascular 26223 (54.5) 16385 (54.8) 9838 (54.1) 0.137
 Diabetes 13061 (27.2) 8436 (28.2) 4625 (25.4) < 0.001
 Hepatic 4949 (10.3) 2960 (9.9) 1989 (10.9) < 0.001
 Renal 7868 (16.4) 5279 (17.7) 2589 (14.2) < 0.001
 Respiratory 10697 (22.2) 7263 (24.3) 3434 (18.9) < 0.001
 Multiple Comorbidities 40123 (83.5) 24819 (83.0) 15304 (84.2) 0.001
Outcome, n (%)
 ICU Mortality 3558 (7.4) 1703 (5.7) 1855 (10.2) < 0.001
 MODS on Day 7 1890 (3.9) 781 (2.6) 1109 (6.1) < 0.001
 New AKI by Day 7 17233 (35.8) 9445 (31.6) 7788 (42.8) < 0.001